Fernandez-Egea E, Vértes PE, Flint SM, Turner L, Mustafa S, Hatton A, Smith KG, Lyons PA, Bullmore ET. Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia. PLoS One. 2016 May 31;11(5):e0155631.
Brown JE, Mezquida G, Fernandez-Egea E. Well-being in clozapine-treated schizophrenia patients: The significance of positive symptoms. Compr Psychiatry. 2016 Jul;68:140-6.
Ziauddeen H, Garcia-Rizo C, Bernardo M, Kirkpatrick B, Ozanne SE, Jones PB, Fernandez-Egea E. Association of birth weight and the development of antipsychotic induced adiposity in individuals with treatment resistant schizophrenia. Eur Neuropsychopharmacol. 2016 Mar 26. pii: S0924-977X(16)30006-2.
Ramos S, Sauras R, Mane A, Mann L, Mundell C, Fernandez-Egea E. An observational study of clozapine induced sedation and its pharmacological management. European Neuropsychopharmacology, 2015 (in press)
Sahakian BJ, Bruhl AB, Cook J, Killikelly C, Savulich G, Piercy T, Hafizi S, Perez J, Fernandez-Egea E, Suckling J, Jones PB (2015), “The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.” Philos Trans R Soc Lond B Biol Sci370(1677)
Garcia-Rizo C, Fernandez-Egea E, Bernardo M, Kirkpatrick B. The thrifty psychiatric phenotype. Acta Psychiatr Scand. 2014 Jul 7. doi: 10.1111/acps.12309. [Epub ahead of print]
Mane A, Garcia-Rizo C, Garcia-Portilla MP, Berge D, Sugranyes G, Garcia-Alvarez L, Bernardo M, Bobes J, Fernandez-Egea E. Spanish adaptation and validation of the Brief Negative Symptoms Scale. Comprehensive Psychiatry (in press).
Fernandez-Egea E, Scoriels L, Theegala S, Giro M, Ozanne SE, Burling K, Jones PB. Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 29. [Epub ahead of print].
Kirkpatrick B, Miller B, García-Rizo C, Fernandez-Egea E. Schizophrenia: a systemic disease. Clin Schizophr Relat Psychosis: 2013 Mar 2:1-23 [Epub ahead of print].
Fernandez-Egea E, Garcia-Rizo C, Zimbron J, Kirkpatrick B. Diabetes or Prediabetes in Newly Diagnosed Patients With Nonaffective Psychosis? A Historical and Contemporary View. Schizophr Bull. 2013 Mar;39(2):266-7
Pons A, Romero A, Goti J, Fernandez-Egea E, Undurruaga J, Carne X, Bernardo M. Should obesity be a limiting factor for clozapine treatment? Rev Psiquiatr Salud Ment. 2013 Apr-Jun;6(2):75-9